First patient enrolled in Erectile Dysfunction prospective randomized study with SELUTION SLR

Reasearch, , , , , , , , , , ,

An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon. Continue reading

Related posts:

  1. Cheap copies of GSK’s HIV prevention drug could be ready in 2026
  2. Taiwan iPreg Inc. to exhibit the newest Sperm Supporting Chip: A New Solution for Infertility at CES 2022 Taiwan Tech Arena Pavilion
  3. Kenya election: four ways to better safeguard and defend democracy
  4. eCential Robotics receives FDA clearance for its surgical robotic platform for spine surgery